Application of IL-2 therapy to target T regulatory cell function
EM Shevach - Trends in immunology, 2012 - cell.com
Interleukin-2 (IL-2) was originally discovered as a growth factor for activated T cells in vitro.
IL-2 promotes CD8+ T cell growth and differentiation in vivo, but has little effect on CD4+ T …
IL-2 promotes CD8+ T cell growth and differentiation in vivo, but has little effect on CD4+ T …
Application of IL-2 therapy to target T regulatory cell function
EM Shevach - Trends in Immunology, 2012 - infona.pl
Interleukin-2 (IL-2) was originally discovered as a growth factor for activated T cells in vitro.
IL-2 promotes CD8+ T cell growth and differentiation in vivo, but has little effect on CD4+ T …
IL-2 promotes CD8+ T cell growth and differentiation in vivo, but has little effect on CD4+ T …
Application of IL-2 therapy to target T regulatory cell function
EM Shevach - Trends in Immunology, 2012 - Elsevier
Interleukin-2 (IL-2) was originally discovered as a growth factor for activated T cells in vitro.
IL-2 promotes CD8+ T cell growth and differentiation in vivo, but has little effect on CD4+ T …
IL-2 promotes CD8+ T cell growth and differentiation in vivo, but has little effect on CD4+ T …
[HTML][HTML] Application of IL-2 therapy to target T regulatory cell function
EM Shevach - Trends in immunology, 2012 - ncbi.nlm.nih.gov
Abstract Interleukin-2 (IL-2) was originally discovered as a growth factor for activated T cells
in vitro. IL-2 promotes CD8+ T cell growth and differentiation in vivo, but has little effect on …
in vitro. IL-2 promotes CD8+ T cell growth and differentiation in vivo, but has little effect on …
Application of IL-2 therapy to target T regulatory cell function.
EM Shevach - Trends in Immunology, 2012 - europepmc.org
Abstract Interleukin-2 (IL-2) was originally discovered as a growth factor for activated T cells
in vitro. IL-2 promotes CD8+ T cell growth and differentiation in vivo, but has little effect on …
in vitro. IL-2 promotes CD8+ T cell growth and differentiation in vivo, but has little effect on …
Application of IL-2 therapy to target T regulatory cell function
EM Shevach - Trends in immunology, 2012 - dialnet.unirioja.es
Resumen Interleukin-2 (IL-2) was originally discovered as a growth factor for activated T
cells in vitro. IL-2 promotes CD8+ T cell growth and differentiation in vivo, but has little effect …
cells in vitro. IL-2 promotes CD8+ T cell growth and differentiation in vivo, but has little effect …
Application of IL-2 therapy to target T regulatory cell function
EM Shevach - Trends in immunology, 2012 - pubmed.ncbi.nlm.nih.gov
Interleukin-2 (IL-2) was originally discovered as a growth factor for activated T cells in vitro.
IL-2 promotes CD8 (+) T cell growth and differentiation in vivo, but has little effect on CD4 (+) …
IL-2 promotes CD8 (+) T cell growth and differentiation in vivo, but has little effect on CD4 (+) …
Application of IL-2 therapy to target T regulatory cell function.
EM Shevach - Trends in Immunology, 2012 - europepmc.org
Abstract Interleukin-2 (IL-2) was originally discovered as a growth factor for activated T cells
in vitro. IL-2 promotes CD8+ T cell growth and differentiation in vivo, but has little effect on …
in vitro. IL-2 promotes CD8+ T cell growth and differentiation in vivo, but has little effect on …